Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html

Study Counts

Type Study_count
Total_Studies 113
interventional 82
Observational 30
Registry 1

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 18
Drug|Radiation 10
Biological 8
Drug|Other 6
Procedure 6
Biological|Drug 3
Device 3
Other 3
Other|Procedure 3
Biological|Drug|Radiation 2
Biological|Other 2
Device|Other 2
Drug|placebo 2
Behavioral 1
Behavioral|Drug|Radiation 1
Behavioral|Other 1
Biological|Device 1
Biological|Drug|Genetic 1
Device|Other|Procedure 1
Device|Procedure 1
Dietary Supplement 1
Dietary Supplement|Other|Procedure|Radiation 1
Drug|Genetic|Procedure 1
Drug|Other|Procedure|Radiation 1
Drug|Other|Radiation 1
Drug|Procedure|Radiation 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 49
France 5
Canada 4
United States|Canada 3
Germany 2
NA 2
United Kingdom 2
United States|Puerto Rico 2
Australia 1
Brazil 1
China 1
Denmark 1
Egypt 1
Germany|Switzerland 1
Italy 1
Norway|Sweden 1
Spain 1
United States|Australia 1
United States|Belgium|Canada|Spain 1
United States|France|Spain 1
United States|South Africa 1

Sites per Study

Site_count Study_Count
1 45
2 5
3 3
4 4
5 1
6 2
7 4
8 1
9 1
10 1
12 1
13 1
15 1
16 1
17 1
18 1
20 1
21 1
31 1
112 1
125 1
172 1
432 1
485 1
858 1

Phase

Phase Study_Count
Phase 2 32
N/A 18
Phase 1 17
Phase 3 8
Phase 1/Phase 2 7

Number of Arms

Number_of_Arms Count_of_Studies
1 48
2 22
3 3
10 1
NA 8

Enrollment Metrics by Phase

Measure N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.3
Min. 4.0000 7.0000 11.00000 20.00000 118.000
1st Qu. 51.0000 23.2500 15.00000 32.75000 204.750
Median 100.0000 38.5000 24.00000 57.00000 446.000
Mean 306.3333 52.0625 57.71429 70.78125 645.625
3rd Qu. 257.2500 78.0000 39.50000 75.50000 620.500
Max. 3000.0000 154.0000 260.00000 252.00000 2520.000

Trial Group Type

group_type Group_Count
Experimental 84
Active Comparator 13
Other 11
NA 8
Placebo Comparator 2
No Intervention 1

Intervention Model

intervention_model Study_Count
Single Group Assignment 49
Parallel Assignment 23
NA 6
Sequential Assignment 4

Primary Purpose

primary_purpose Study_Count
Treatment 62
Screening 7
Prevention 5
Supportive Care 5
Diagnostic 2
Other 1

Observational Studies

Studies by Country

Country Study_Count
United States 13
France 4
NA 2
Sweden 2
Australia 1
Brazil 1
Canada 1
Costa Rica 1
Denmark 1
Germany 1
Norway 1
Spain 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 24
2 1
4 1
5 1
13 1
14 1
15 1

Enrollment Metrics

Measure Observational
Min 7.0
1st Qu 91.5
Median 169.5
Mean 78065.9
3rd Qu 478.0
Max 2323608.0

Observation Model

observational_model Study_Count
Cohort 20
Case-Control 4
Case-Only 3
NA 2
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 23
Retrospective 5
Cross-Sectional 2

Registries

Studies by Country

Country Study_Count
United States 1

Sites per Study

Site_count Study_Count
75 1

Enrollment Metrics

Measure Registries
Min 999999
1st Qu 999999
Median 999999
Mean 999999
3rd Qu 999999
Max 999999

Registry Model

observational_model Study_Count
Cohort 1

Time Perspective

time_perspective Study_Count
Prospective 1

Follow-up

target_duration Study_Count
80 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03499795 VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2 https://ClinicalTrials.gov/show/NCT03499795 Active, not recruiting Inovio Pharmaceuticals 2021-05-31
NCT03381352 Study of IMRT Radiotherapy Concurrent Chemothrerapy for Anal Cancer https://ClinicalTrials.gov/show/NCT03381352 Recruiting Chinese Academy of Medical Sciences 2018-12-31
NCT03357757 Avelumab With Valproic Acid in Virus-associated Cancer https://ClinicalTrials.gov/show/NCT03357757 Recruiting AHS Cancer Control Alberta 2022-03-30
NCT03302858 A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRXâ„¢ Anorectal Wand https://ClinicalTrials.gov/show/NCT03302858 Recruiting Laser Surgery Care 2019-10-31
NCT03221400 PEN-866 in Patients With Advanced Solid Malignancies https://ClinicalTrials.gov/show/NCT03221400 Recruiting Tarveda Therapeutics 2021-12-31
NCT03202992 Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection https://ClinicalTrials.gov/show/NCT03202992 Completed Antiva Biosciences 2019-02-04
NCT03113942 Study of Pomalidomide in Anal Cancer Precursors https://ClinicalTrials.gov/show/NCT03113942 Active, not recruiting Kirby Institute 2019-03-31
NCT03061435 Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. https://ClinicalTrials.gov/show/NCT03061435 Recruiting Sunnybrook Health Sciences Centre 2020-12-31
NCT03233711 Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer https://ClinicalTrials.gov/show/NCT03233711 Recruiting National Cancer Institute (NCI) 2021-12-30
NCT03018418 Proton Therapy in Reducing Toxicity in Anal Cancer https://ClinicalTrials.gov/show/NCT03018418 Recruiting University of Cincinnati 2022-06-30
NCT02981862 CaptHPV : Validation of the Method “CaptHPV” for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas https://ClinicalTrials.gov/show/NCT02981862 Completed Institut de Cancérologie de Lorraine 2018-06-12
NCT02865135 Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer https://ClinicalTrials.gov/show/NCT02865135 Active, not recruiting Dana-Farber Cancer Institute 2020-12-31
NCT02816879 Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT02816879 Active, not recruiting Jonsson Comprehensive Cancer Center 2020-07-31
NCT02785263 Shared Decision Making With Anal Cancer Patients on Radiation Dose https://ClinicalTrials.gov/show/NCT02785263 Recruiting Vejle Hospital 2021-03-31
NCT02701088 Study of SIB-IMRT in Combination With 5-FU and Mitomycin-C Among Patients With Locally Advanced Anal Canal Cancer: Efficacy, Safety and Quality of Life https://ClinicalTrials.gov/show/NCT02701088 Recruiting Centre Francois Baclesse 2020-12-31
NCT02560298 Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer https://ClinicalTrials.gov/show/NCT02560298 Active, not recruiting Eastern Cooperative Oncology Group 2020-08-31
NCT02526953 Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients https://ClinicalTrials.gov/show/NCT02526953 Enrolling by invitation Blokhin’s Russian Cancer Research Center 2021-10-31
NCT02503111 The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT02503111 Enrolling by invitation University Health Network, Toronto 2020-11-30
NCT02489422 Programs To Support You During Chemotherapy https://ClinicalTrials.gov/show/NCT02489422 Completed Wake Forest University Health Sciences 2020-01-31
NCT02437851 Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection https://ClinicalTrials.gov/show/NCT02437851 Active, not recruiting AIDS Malignancy Consortium 2025-08-31
NCT02402842 Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma https://ClinicalTrials.gov/show/NCT02402842 Active, not recruiting Centre Hospitalier Universitaire de Besancon 2018-06-30
NCT02399813 Phase 2 Study of ADXS11-001 in Subjects With Carcinoma of the Anorectal Canal https://ClinicalTrials.gov/show/NCT02399813 Completed Advaxis, Inc. 2017-06-30
NCT02384005 The Feasibility of Self or Partner-assisted Digital Anal Exam Screening https://ClinicalTrials.gov/show/NCT02384005 Completed The University of Texas Health Science Center, Houston 2016-04-30
NCT02379520 HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA https://ClinicalTrials.gov/show/NCT02379520 Recruiting Baylor College of Medicine 2020-10-31
NCT02369939 Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy https://ClinicalTrials.gov/show/NCT02369939 Recruiting University of Erlangen-Nürnberg Medical School 2017-12-31
NCT03386500 Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer https://ClinicalTrials.gov/show/NCT03386500 Recruiting University of Nebraska 2021-12-31
NCT02280811 T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers https://ClinicalTrials.gov/show/NCT02280811 Completed National Institutes of Health Clinical Center (CC) 2016-06-28
NCT02199236 Dose Escalation Trial of Endoluminal High-Dose-Rate Brachytherapy With Concurrent Chemotherapy for Rectal or Anal Cancer in Patients With Recurrent Disease or Undergoing Non-Operative Management https://ClinicalTrials.gov/show/NCT02199236 Recruiting Memorial Sloan Kettering Cancer Center 2021-07-31
NCT02140021 Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer https://ClinicalTrials.gov/show/NCT02140021 Recruiting M.D. Anderson Cancer Center 2020-10-31
NCT01285778 Vectibix for the Treatment of Anal Cancer https://ClinicalTrials.gov/show/NCT01285778 Completed Grupo Espanol Multidisciplinario del Cancer Digestivo 2017-03-24
NCT01946139 Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV https://ClinicalTrials.gov/show/NCT01946139 Completed AIDS Malignancy Consortium 2018-10-31
NCT01717391 [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers https://ClinicalTrials.gov/show/NCT01717391 Completed University of Iowa 2016-02-29
NCT01621217 Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 https://ClinicalTrials.gov/show/NCT01621217 Completed Lund University Hospital 2020-01-31
NCT01585428 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers https://ClinicalTrials.gov/show/NCT01585428 Completed National Institutes of Health Clinical Center (CC) 2016-04-09
NCT01581840 Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus https://ClinicalTrials.gov/show/NCT01581840 Active, not recruiting Federation Francophone de Cancerologie Digestive 2018-09-30
NCT01526486 Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer https://ClinicalTrials.gov/show/NCT01526486 Completed Emory University 2013-02-28
NCT04287868 Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies https://ClinicalTrials.gov/show/NCT04287868 Recruiting National Institutes of Health Clinical Center (CC) 2021-07-30
NCT04230759 Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group https://ClinicalTrials.gov/show/NCT04230759 Recruiting Goethe University 2023-03-31
NCT04166318 Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study https://ClinicalTrials.gov/show/NCT04166318 Recruiting Eastern Cooperative Oncology Group 2025-07-01
NCT04094454 Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy https://ClinicalTrials.gov/show/NCT04094454 Recruiting University Hospital Heidelberg 2023-10-31
NCT04066894 Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study https://ClinicalTrials.gov/show/NCT04066894 Recruiting M.D. Anderson Cancer Center 2025-07-31
NCT03983174 Drainage Seton With Flap Versus EAS Preserving Seton in Treatment of Transsphincteric Anal Fistula https://ClinicalTrials.gov/show/NCT03983174 Completed Mansoura University 2018-04-30
NCT03894618 SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas https://ClinicalTrials.gov/show/NCT03894618 Recruiting Shattuck Labs, Inc. 2022-02-02
NCT03346915 Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention https://ClinicalTrials.gov/show/NCT03346915 Completed Boston Medical Center 2019-04-19
NCT03519295 A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma https://ClinicalTrials.gov/show/NCT03519295 Recruiting GERCOR - Multidisciplinary Oncology Cooperative Group 2020-06-30
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03517488 Recruiting Xencor, Inc. 2020-12-31
NCT03439085 DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers https://ClinicalTrials.gov/show/NCT03439085 Recruiting M.D. Anderson Cancer Center 2020-01-31
NCT03427411 M7824 in Subjects With HPV Associated Malignancies https://ClinicalTrials.gov/show/NCT03427411 Recruiting National Institutes of Health Clinical Center (CC) 2021-12-31
NCT01209325 Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males https://ClinicalTrials.gov/show/NCT01209325 Completed AIDS Malignancy Consortium 2017-12-12
NCT01170299 Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer https://ClinicalTrials.gov/show/NCT01170299 Completed National Cancer Institute (NCI) 2012-12-31
NCT01164722 Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia https://ClinicalTrials.gov/show/NCT01164722 Completed AIDS Malignancy Consortium 2015-07-31
NCT01104181 Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test https://ClinicalTrials.gov/show/NCT01104181 Completed Laser Surgery Care 2010-12-31
NCT00955591 Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT00955591 Completed Jonsson Comprehensive Cancer Center 2011-12-12
NCT03870607 Prebiotics and Probiotics During Definitive Treatment With Chemotherapy-radiotherapy SCC of the Anal Canal (BISQUIT) https://ClinicalTrials.gov/show/NCT03870607 Recruiting AC Camargo Cancer Center 2022-08-13
NCT04157985 Evaluation of the Length of Treatment With PD-1/PD-L1 Inhibitors in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT04157985 Recruiting University of Pittsburgh 2021-10-31
NCT03944252 Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS) https://ClinicalTrials.gov/show/NCT03944252 Active, not recruiting Gruppo Oncologico del Nord-Ovest 2021-02-28
NCT03690921 LET-IMPT and Standard Chemotherapy in Treating Patients With Newly Diagnosed Stage I-III Anal Canal Squamous Cell Cancer https://ClinicalTrials.gov/show/NCT03690921 Recruiting M.D. Anderson Cancer Center 2022-05-23
NCT01651949 Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) https://ClinicalTrials.gov/show/NCT01651949 Completed Merck Sharp & Dohme Corp. 2014-08-04
NCT04234113 Study of SO-C101 and SO-C101in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT04234113 Recruiting Sotio a.s. 2022-03-31
NCT02919969 Pembrolizumab in Refractory Metastatic Anal Cancer https://ClinicalTrials.gov/show/NCT02919969 Recruiting Dana-Farber Cancer Institute 2020-03-31
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00654160 Completed Mayo Clinic 2010-11-30
NCT00622440 Treatment of Anal High-grade Squamous Intraepithelial Lesions (HSIL) Through Use of a Chinese Herbal Topical Cream https://ClinicalTrials.gov/show/NCT00622440 Completed University of California, San Francisco 2012-12-12
NCT00428285 Tolerability, Safety, & Efficacy of Argon Plasma Coagulation to Treat Anal Intraepithelial Neoplasia in HIV-Positive Men https://ClinicalTrials.gov/show/NCT00428285 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2010-02-28
NCT00423293 Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer https://ClinicalTrials.gov/show/NCT00423293 Completed Radiation Therapy Oncology Group 2009-02-28
NCT00397384 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer https://ClinicalTrials.gov/show/NCT00397384 Completed National Cancer Institute (NCI) 2013-06-30
NCT00324415 Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer https://ClinicalTrials.gov/show/NCT00324415 Completed AIDS Malignancy Consortium 2014-04-30
NCT00316888 Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer https://ClinicalTrials.gov/show/NCT00316888 Active, not recruiting Eastern Cooperative Oncology Group 2015-11-30
NCT00093379 Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer https://ClinicalTrials.gov/show/NCT00093379 Completed M.D. Anderson Cancer Center 2012-07-31
NCT00003427 Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00003427 Completed Memorial Sloan Kettering Cancer Center 2002-04-30
NCT00003046 Interleukin-12 in Treating Patients With Cancer in the Abdomen https://ClinicalTrials.gov/show/NCT00003046 Completed M.D. Anderson Cancer Center 2001-10-31
NCT00075868 Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer https://ClinicalTrials.gov/show/NCT00075868 Completed Radiation Therapy Oncology Group 2006-08-31
NCT00004074 Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu https://ClinicalTrials.gov/show/NCT00004074 Completed National Cancer Institute (NCI) 2009-02-28
NCT00066430 Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia https://ClinicalTrials.gov/show/NCT00066430 Completed AIDS Malignancy Consortium 2004-09-30
NCT00059891 Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer https://ClinicalTrials.gov/show/NCT00059891 Completed Memorial Sloan Kettering Cancer Center 2009-10-31
NCT00052897 SGN-00101 in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia https://ClinicalTrials.gov/show/NCT00052897 Completed National Cancer Institute (NCI) 2005-07-31
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00030498 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction https://ClinicalTrials.gov/show/NCT00030498 Completed National Cancer Institute (NCI) 2007-07-31
NCT00025090 Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer https://ClinicalTrials.gov/show/NCT00025090 Completed National Cancer Institute (NCI) NA
NCT00019110 Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer https://ClinicalTrials.gov/show/NCT00019110 Completed National Cancer Institute (NCI) NA
NCT00003596 Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer https://ClinicalTrials.gov/show/NCT00003596 Completed Radiation Therapy Oncology Group 2005-10-31
NCT00550589 Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus https://ClinicalTrials.gov/show/NCT00550589 Completed AIDS Malignancy Consortium 2010-02-28
NCT00000764 Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection. https://ClinicalTrials.gov/show/NCT00000764 Completed National Institute of Allergy and Infectious Diseases (NIAID) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03133286 Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) https://ClinicalTrials.gov/show/NCT03133286 Recruiting DxTerity Diagnostics 2019-09-06
NCT02949596 Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy https://ClinicalTrials.gov/show/NCT02949596 Active, not recruiting Instituto do Cancer do Estado de São Paulo 2020-10-31
NCT02873741 New Strategies to Assess Anal Cancer Risk In Women https://ClinicalTrials.gov/show/NCT02873741 Completed Emory University 2017-02-27
NCT02379039 Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer https://ClinicalTrials.gov/show/NCT02379039 Recruiting Umeå University 2021-05-31
NCT02546973 Quality of Life in Patients With Anal Cancer https://ClinicalTrials.gov/show/NCT02546973 Recruiting Sahlgrenska University Hospital, Sweden 2021-09-30
NCT02145416 ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy https://ClinicalTrials.gov/show/NCT02145416 Completed University of Oxford 2017-12-08
NCT01937780 Anal Cancer Radiotherapy Study https://ClinicalTrials.gov/show/NCT01937780 Active, not recruiting Oslo University Hospital 2021-09-30
NCT01567722 Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies https://ClinicalTrials.gov/show/NCT01567722 Recruiting AIDS Malignancy Consortium 2020-06-30
NCT01416714 Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy https://ClinicalTrials.gov/show/NCT01416714 Recruiting University of Chicago 2025-01-31
NCT01379872 Assessment of New Radiation Oncology Technologies and Treatments https://ClinicalTrials.gov/show/NCT01379872 Completed Trans-Tasman Radiation Oncology Group (TROG) 2012-05-31
NCT03792854 Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE) https://ClinicalTrials.gov/show/NCT03792854 Recruiting Ludwig-Maximilians - University of Munich 2021-12-31
NCT03713229 Seville Cohort of People Living With HIV at Risk for Anal Cancer https://ClinicalTrials.gov/show/NCT03713229 Enrolling by invitation Hospitales Universitarios Virgen del Rocío 2025-12-31
NCT03506529 Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CT https://ClinicalTrials.gov/show/NCT03506529 Completed Centre Francois Baclesse 2018-11-15
NCT03469596 Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor? https://ClinicalTrials.gov/show/NCT03469596 Completed Groupe Hospitalier Paris Saint Joseph 2017-05-01
NCT03465501 Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates https://ClinicalTrials.gov/show/NCT03465501 Completed Institut Paoli-Calmettes 2016-07-28
NCT01236053 Cancer in Patients With Gabapentin (GPRD) https://ClinicalTrials.gov/show/NCT01236053 Completed GlaxoSmithKline 2010-09-30
NCT01135849 B-Receptor Signaling in Cardiomyopathy https://ClinicalTrials.gov/show/NCT01135849 Completed Stanford University 2010-10-31
NCT00836992 Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer https://ClinicalTrials.gov/show/NCT00836992 Completed Mayo Clinic 2011-09-15
NCT00914537 Anal Cancer Screening Study https://ClinicalTrials.gov/show/NCT00914537 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT00867464 Extended Follow-Up of Young Women in Costa Rica Who Received Vaccination Against Human Papillomavirus Types 16 and 18 and Unvaccinated Controls https://ClinicalTrials.gov/show/NCT00867464 Active, not recruiting National Institutes of Health Clinical Center (CC) NA
NCT02697084 Individual Following in Anal Cancer With PET/CT https://ClinicalTrials.gov/show/NCT02697084 Recruiting Centre Antoine Lacassagne 2020-09-30
NCT00789893 Study of Vaginal Dilator Use After Pelvic Radiotherapy https://ClinicalTrials.gov/show/NCT00789893 Completed Memorial Sloan Kettering Cancer Center 2015-06-30
NCT00693173 Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients https://ClinicalTrials.gov/show/NCT00693173 Completed The University of Texas Medical Branch, Galveston 2009-06-30
NCT00661154 Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project https://ClinicalTrials.gov/show/NCT00661154 Completed Stanford University 2009-07-31
NCT00502502 Assessment of Symptom-Related Cytokines in Lung and Gastrointestinal (GI) Cancer Patients https://ClinicalTrials.gov/show/NCT00502502 Completed M.D. Anderson Cancer Center 2010-07-31
NCT00501306 Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men https://ClinicalTrials.gov/show/NCT00501306 Completed Laser Surgery Care 2008-05-31
NCT00799474 Men’s Beliefs About Associations Between HPV, Cancers, and HPV Vaccination https://ClinicalTrials.gov/show/NCT00799474 Completed University of North Carolina, Chapel Hill 2009-01-31
NCT00302094 Image Fusion PET, CT and 3D-ultrasound Examinations https://ClinicalTrials.gov/show/NCT00302094 Completed Rigshospitalet, Denmark 2009-04-30
NCT00188292 Screening for HIV-Associated Anal Cancer https://ClinicalTrials.gov/show/NCT00188292 Completed University Health Network, Toronto 2012-06-30
NCT00107679 A Study of Anal Cancer Development in HIV Infected People https://ClinicalTrials.gov/show/NCT00107679 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2006-03-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02012699 Integrated Cancer Repository for Cancer Research https://ClinicalTrials.gov/show/NCT02012699 Recruiting University of Nebraska 2099-12-31